RESUMEN
CONTEXT: The roles of interleukin 10 (IL-10) and IL-12 in regulation of cancer growth and Th1/Th2 immune responses towards cancer are unclear. OBJECTIVE: To establish the prognostic significance of serum IL-10 and IL-12 in paediatric soft tissue sarcomas (STS). MATERIALS AND METHODS: ELISA determinations of cytokines were performed as pre-treatment in 59 children with STS and 30 healthy controls. RESULTS: Elevated IL-10 and decreased IL-12 serum levels correlated with advanced disease, poor response to chemotherapy and poor outcome. IL-10 ≥ 9.5 pg/ml, IL-12 ≤ 65 pg/ml and lymph nodes involvement independently predicted poor overall survival (OS) in multivariate Cox analysis. CONCLUSION: Serum IL-10/IL-12 balance determination may facilitate to assess risk groups and prognosis in childhood STS.
Asunto(s)
Interleucina-10/sangre , Interleucina-12/sangre , Rabdomiosarcoma Alveolar/sangre , Rabdomiosarcoma Embrionario/sangre , Sarcoma/sangre , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Lactante , Interleucina-10/inmunología , Interleucina-12/inmunología , Metástasis Linfática , Masculino , Estadificación de Neoplasias , Pronóstico , Rabdomiosarcoma Alveolar/diagnóstico , Rabdomiosarcoma Alveolar/inmunología , Rabdomiosarcoma Alveolar/mortalidad , Rabdomiosarcoma Embrionario/diagnóstico , Rabdomiosarcoma Embrionario/inmunología , Rabdomiosarcoma Embrionario/mortalidad , Sarcoma/diagnóstico , Sarcoma/inmunología , Sarcoma/mortalidad , Análisis de Supervivencia , Balance Th1 - Th2RESUMEN
A subcutaneous mass on the left antebrachium of an 11-year-old intact female English Pointer dog was evaluated presurgically by cytologic examination and immunocytochemical staining. The sample consisted of discrete, variably sized, markedly pleomorphic neoplastic cells that expressed vimentin with diffuse cytoplasmic staining, desmin with focal paranuclear staining, and myoglobin with diffuse cytoplasmic staining, consistent with a diagnosis of rhabdomyosarcoma. Lymphocytic and histiocytic markers were negative. Aspirates of the enlarged ipsilateral prescapular lymph node were positive for metastatic disease. Surgical excision of the tumor and lymph node were followed by histologic and electron microscopic examination. Histomorphologic appearance of neoplastic cells from the mass and the lymph node paralleled cytologic findings; the histologic diagnosis was round cell variant of embryonal rhabdomyosarcoma. By ultrastructural evaluation, cells contained numerous mitochondria and masses of cytoplasmic tangled myofilaments, features typical of rhabdomyoblasts. The dog received doxorubicin (30 mg/m(2) ) every 3 weeks for 5 treatments. Local recurrence developed 6 months after resection but was not treated. Despite a guarded prognosis and untreated local recurrence, the dog was still alive 18 months after surgery. Cytologic evaluation and immunocytochemical staining were pivotal for the presurgical diagnosis of rhabdomyosarcoma.
Asunto(s)
Enfermedades de los Perros/patología , Rabdomiosarcoma Embrionario/veterinaria , Neoplasias Cutáneas/veterinaria , Animales , Enfermedades de los Perros/sangre , Perros , Femenino , Metástasis Linfática , Rabdomiosarcoma Embrionario/sangre , Rabdomiosarcoma Embrionario/patología , Rabdomiosarcoma Embrionario/ultraestructura , Neoplasias Cutáneas/sangre , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/ultraestructura , Tejido Subcutáneo/patologíaRESUMEN
Presently there is no serum biomarker of rhabdomyosarcoma (RMS). Several studies have shown that profiles of microRNA (miRNA) expression differ among tumor types. Here we evaluated the feasibility of using muscle-specific miRNAs (miR-1, -133a, -133b and -206) as biomarkers of RMS. Expression of muscle-specific miRNAs, especially miR-206, was significantly higher in RMS cell lines than in other tumor cell lines, as well as in RMS tumor specimens. Further, serum levels of muscle-specific miRNAs were significantly higher in patients with RMS tumors than in patients with non-RMS tumors. Normalized serum miR-206 expression level could be used to differentiate between RMS and non-RMS tumors, with sensitivity of 1.0 and specificity of 0.913. These results raise the possibility of using circulating muscle-specific miRNAs, especially miR-206, as landmark biomarkers for RMS.
Asunto(s)
Biomarcadores de Tumor/sangre , MicroARNs/sangre , Rabdomiosarcoma Alveolar/diagnóstico , Rabdomiosarcoma Embrionario/diagnóstico , Adolescente , Biomarcadores de Tumor/metabolismo , Línea Celular Tumoral , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , MicroARNs/metabolismo , Músculo Esquelético/metabolismo , Rabdomiosarcoma Alveolar/sangre , Rabdomiosarcoma Embrionario/sangreRESUMEN
PURPOSE: To assess if molecular detection of minimal disseminated disease by real-time reverse transcription and polymerase chain reaction (RT-PCR) could contribute to a better treatment stratification in patients with rhabdomyosarcoma (RMS). METHODS: Relative quantification of the tumor-mRNA present in serial samples of bone marrow (BM) and peripheral blood (PB) from 16 patients with RMS (7 alveolar and 9 embryonal) was performed by a real-time RT-PCR assay. Expression of MyoD1 and acetylcholine receptor (AChR) was analyzed in all samples, along with PAX3/7-FKHR in samples from alveolar tumors. RESULTS: A good correlation was found between the expression of PAX3/7-FKHR and AChR, while MyoD1 was more sensitive but less specific. In this study, patients with positive PB at the end of treatment showed a poorer prognosis than patients with negative PB. Moreover, in this patient cohort, metastatic relapses were preceded by the detection of microcirculating disease in all cases. CONCLUSION: The detection of minimal circulating and micrometastatic disease by real-time RT-PCR, based on the expression of multiple genes, yields highly reproducible results. Patients with positive PB after treatment show poorer survival than patients without microcirculating disease.
Asunto(s)
Neoplasias de la Médula Ósea/diagnóstico , Neoplasias de la Médula Ósea/secundario , Células Neoplásicas Circulantes , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Rabdomiosarcoma Alveolar/diagnóstico , Rabdomiosarcoma Embrionario/diagnóstico , Adolescente , Biomarcadores de Tumor/genética , Neoplasias de la Médula Ósea/genética , Niño , Preescolar , Estudios de Cohortes , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Perfilación de la Expresión Génica , Humanos , Lactante , Masculino , Proteína MioD/genética , Estadificación de Neoplasias , Neoplasia Residual , Células Neoplásicas Circulantes/metabolismo , Proteínas de Fusión Oncogénica/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptores Nicotínicos/genética , Recurrencia , Estudios Retrospectivos , Rabdomiosarcoma Alveolar/sangre , Rabdomiosarcoma Alveolar/genética , Rabdomiosarcoma Embrionario/sangre , Rabdomiosarcoma Embrionario/genética , Sensibilidad y Especificidad , Tasa de SupervivenciaRESUMEN
The case of a woman who developed a cervical sarcoma botryoides tumor at age 14 years and a right ovarian Sertoli-Leydig cell tumor with alpha-fetoprotein production at 27 years is presented. The sarcoma botryoides was a stage 1b, 4-cm, polypoid ectocervical tumor treated by radical hysterectomy and bilateral pelvic lymphadenectomy. The Sertoli-Leydig cell tumor was a stage 1a, 145-g mass removed piecemeal by right oophorectomy. Histologically, it was an intermediate Sertoli-Leydig cell tumor with a heterologous element composed of an endometrioid-like yolk sac tumor which was producing alpha-fetoprotein. There was no histological similarity between the two tumors. The patient is alive without evidence of disease, 16 years after diagnosis of her sarcoma botryoides and 3 years after her Sertoli-Leydig cell tumor. This is, to our knowledge, the third known association between these two rare gynecological tumors. The basis of the association remains unknown.